AU3283789A - Immunogenic glycoproteins of human cytomegalovirus - Google Patents
Immunogenic glycoproteins of human cytomegalovirusInfo
- Publication number
- AU3283789A AU3283789A AU32837/89A AU3283789A AU3283789A AU 3283789 A AU3283789 A AU 3283789A AU 32837/89 A AU32837/89 A AU 32837/89A AU 3283789 A AU3283789 A AU 3283789A AU 3283789 A AU3283789 A AU 3283789A
- Authority
- AU
- Australia
- Prior art keywords
- human cytomegalovirus
- glycoproteins
- immunogenic
- immunogenic glycoproteins
- cytomegalovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
- C07K16/089—Cytomegalovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15838988A | 1988-02-22 | 1988-02-22 | |
| US158389 | 1993-11-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3283789A true AU3283789A (en) | 1989-09-06 |
Family
ID=22567884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU32837/89A Abandoned AU3283789A (en) | 1988-02-22 | 1989-01-25 | Immunogenic glycoproteins of human cytomegalovirus |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0403541A4 (en) |
| JP (1) | JPH03502799A (en) |
| KR (1) | KR900700509A (en) |
| AU (1) | AU3283789A (en) |
| WO (1) | WO1989007615A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5124440A (en) * | 1986-11-24 | 1992-06-23 | The Childrens Hospital, Inc. | Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus |
| US5807557A (en) * | 1994-07-25 | 1998-09-15 | The Trustees Of The University Of Pennsylvania | Soluble herpesvirus glycoprotein complex |
| US6156319A (en) | 1994-07-25 | 2000-12-05 | The Trustees Of The University Of Pennsylvania | Soluble herpesvirus glycoprotein complex vaccine |
| CA2212682A1 (en) | 1995-02-10 | 1996-08-15 | Worcester Foundation For Experimental Biology, Inc. | Delivery of exogenous compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4689225A (en) * | 1984-11-02 | 1987-08-25 | Institut Merieux | Vaccine for cytomegalovirus |
| US5126130A (en) * | 1986-11-24 | 1992-06-30 | The Childrens Hospital Incorporated | Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a |
-
1989
- 1989-01-25 AU AU32837/89A patent/AU3283789A/en not_active Abandoned
- 1989-01-25 JP JP1503283A patent/JPH03502799A/en active Pending
- 1989-01-25 EP EP19890903633 patent/EP0403541A4/en not_active Withdrawn
- 1989-01-25 WO PCT/US1989/000318 patent/WO1989007615A1/en not_active Ceased
- 1989-10-21 KR KR1019890701929A patent/KR900700509A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1989007615A1 (en) | 1989-08-24 |
| EP0403541A1 (en) | 1990-12-27 |
| JPH03502799A (en) | 1991-06-27 |
| EP0403541A4 (en) | 1991-01-09 |
| KR900700509A (en) | 1990-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4285889A (en) | Preparation of catheter | |
| AU7746487A (en) | Surgical prosthesis | |
| AU3522189A (en) | Preparation of lower polyhydric alcohols | |
| AU2189588A (en) | Artificial skin | |
| AU5181190A (en) | Multifunctional facial tissue | |
| AU3437389A (en) | Process of preparing hydroxylapatite | |
| AU8015587A (en) | 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols | |
| AU3967889A (en) | Immunogenic glycoproteins of human cytomegalovirus gcii | |
| AU5405390A (en) | Early envelope glycoproteins of human cytomegalovirus (hmcv) | |
| AU613543B2 (en) | Preparation of halofluorobenzenes | |
| AU7412787A (en) | Glycoprotein of human cytomegalovirus | |
| AU4552389A (en) | Preparation of n-acyl-aminomethylphosphonates | |
| AU3283789A (en) | Immunogenic glycoproteins of human cytomegalovirus | |
| GB2220000B (en) | Preparation of iodoalkynyl carbamates | |
| NZ227594A (en) | Human interleukin-1alpha and preparations thereof | |
| IL91422A0 (en) | Cosmetic preparation | |
| AU3434489A (en) | Skin treatment formulations | |
| AU3549489A (en) | Human gm-csf variants | |
| AU6357890A (en) | Expression of alpha-macroglobulins | |
| AU5050490A (en) | Human monocyte-macrophage-csf preparations | |
| AU4958690A (en) | Preparation of 2-halofluorobenzene | |
| AU3048689A (en) | Immunogenic peptides | |
| AU584704B2 (en) | Ocular prosthesis | |
| AU6966891A (en) | Detection of human adenovirus | |
| AU3651689A (en) | Cloning and expression of human tissue factor |